- Home
- RAPT vs BWMX Comparison
RAPT vs BWMX Comparison
Compare RAPT & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAPT | BWMX |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | United States | Mexico |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.4M | 495.6M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | RAPT | BWMX |
|---|---|---|
| Price | $34.24 | $14.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $57.00 | $22.50 |
| AVG Volume (30 Days) | ★ 412.1K | 30.1K |
| Earning Date | 11-06-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 10.36% |
| EPS Growth | N/A | ★ 15.49 |
| EPS | N/A | ★ 1.49 |
| Revenue | N/A | ★ $775,128,445.00 |
| Revenue This Year | N/A | $3.50 |
| Revenue Next Year | N/A | $5.30 |
| P/E Ratio | ★ N/A | $9.54 |
| Revenue Growth | N/A | ★ 3.60 |
| 52 Week Low | $5.67 | $7.00 |
| 52 Week High | $42.39 | $15.00 |
Technical Indicators
Market Signals| Indicator | RAPT | BWMX |
|---|---|---|
| Relative Strength Index (RSI) | 65.62 | 52.77 |
| Support Level | $30.00 | $14.26 |
| Resistance Level | $35.10 | $14.65 |
| Average True Range (ATR) | 2.03 | 0.42 |
| MACD | 0.42 | -0.01 |
| Stochastic Oscillator | 84.06 | 60.43 |
Price Performance
Historical ComparisonAbout RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.